Furthermore, silencing of Fra-2 or JunD in CTCL cell lines led to the suppression of cell growth and downregulation of CCR4 expression, supporting the oncogenic and CCR4-inducing roles of Fra-2/JunD in CTCLs as in ATLL [141]. This evidence concerns the gene FOSL2 and primary cutaneous T-cell non-Hodgkin lymphoma.